OUR PRODUCTS

MOBILE APPS

GENERAL INFO

APGE

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Apogee Therapeutics (APGE) Earnings Date & Reports

Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

APGE is expected to report earnings to fall 46.02% to -61 cents per share on November 18

Apogee Therapeutics APGE Stock Earnings Reports

Q3'25

Est.

$-0.61

Q2'25

Missed

by $0.51

Q1'25

Missed

by $0.37

Q4'24

Missed

by $0.56

Q3'24

Missed

by $0.30

The last earnings report on August 11 showed earnings per share of -112 cents, missing the estimate of -62 cents. With 235.37K shares outstanding, the current market capitalization sits at 2.20B.

View a ticker or compare two or three

Compare

APGE

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For APGE
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. APGE showed earnings on August 11, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

221 Crescent Street

Phone

+1 650 394-5230

Employees

Web

https://www.apogeetherapeutics.com